FOLH1 and prostate cancer: An exploratory analysis revealed a potential age-dependent pattern, but this requires confirmation in larger studies.<h4>Conclusions</h4>In this select cohort, PSMA PET/CT demonstrated greater accuracy than MRI for locoregional staging in patients with intermediate-to-high-risk prostate cancer (PCa).